Clinical trial
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine…
NCT00070213 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00070213 |
|---|---|
| Title | Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Drug Treatment for Bowel Cancer: Making the Best Choices When a Milder Treatment is Needed |
| Lead sponsor | Medical Research Council, Other |
| Collaborators | University of Leeds |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | FOLFOX regimen, capecitabine, fluorouracil, leucovorin calcium, oxaliplatin, quality-of-life assessment |
| Enrollment | 460 |
| Start date | Sep 1, 2003 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Oct 7, 2003 |
| Last update posted | Sep 27, 2021 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: